Definitive Radiotherapy or Chemoradiotherapy in the Treatment of Merkel Cell Carcinoma

Clinical Oncology

Volumn 24, Issue 9, 2012, Pages

  Sundaresan, P ^a,b   Hruby, G ^a,b   Hamilton, A ^a,b   Hong, A ^a,b   Boyer, M ^a,b   Chatfield, M ^c   Thompson, J F ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

Chemoradiation; Chemotherapy; Definitive treatment; Merkel cell carcinoma; Non surgical treatment; Radiotherapy

Indexed keywords

CARBOPLATIN; ETOPOSIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MALE; MERKEL CELL TUMOR; METASTASIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT CANCER; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, MERKEL CELL; CHEMORADIOTHERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84866848235     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.04.007     Document Type: Article

References (26)

1. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972, 105:107-110.
2. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol 2004, 5(10):593-599.
3. Goessling W., McKee P., Mayer R. Merkel cell carcinoma. J Clin Oncol 2002, 20:588-598.
4. Socinski M.A., Bogart J.A. Limited-stage small-cell lung cancer: the current status of combined-modality therapy. J Clin Oncol 2007, 25:4137-4145.
5. Warner R.E., Quinn M., Hruby G., et al. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol 2008, 15(9):2509-2518.
6. Tsang G., O'Brien P., Robertson R., et al. All delays before radiotherapy risk progression of Merkel cell carcinoma. Australas Radiol 2004, 48(3):371-375.
7. Mortier L., Mirabel X., Fournier C., et al. Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003, 139:1587-1590.
8. Ashby M.A., Jones D.H., Tasker A.D., et al. Primary cutaneous neuroendocrine (Merkel cell or trabecular carcinoma) tumour of the skin: a radioresponsive tumour. Clin Radiol 1989, 40:85-87.
9. Pacella J., Ashby M., Ainslie J., et al. The role of radiotherapy in the management of primary cutaneous neuroendocrine tumors (Merkel cell or trabecular carcinoma): experience at the Peter MacCallum Cancer Institute (Melbourne, Australia). Int J Radiat Oncol Biol Phys 1988, 14:1077-1084.
10. Suntharalingam M., Rudolz M., Mendenhall W.M., et al. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head Neck 1995, 17:96-101.
11. Veness M.J., Foote M., Gebski V., et al. The role of radiotherapy alone in patients with Merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys 2010, 78(3):703-709.
12. Yiengpruksawan A., Coit D.G., Thaler H.T., et al. Merkel cell carcinoma. Prognosis and management. Arch Surg 1991, 126(12):1514-1519.
13. Trans Tasman Radiation Oncology Group (TROG). A phase II efficacy study of chemo-radiotherapy in positron emission tomography (PET) stage II and III Merkel cell carcinoma of the skin. Clinical Trials NCTO10137792009.
14. Poulsen M., Rischin D., Walpole E., et al. Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study. Int J Radiat Oncol Biol Phys 2001, 51(1):156-163.
15. Poulsen M., Rischin D., Walpole E., et al. High risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study, TROG 96:07. J Clin Oncol 2003, 21(23):4371-4376.
16. Jabbour J., Cummin R., Scolyer R.A., et al. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection and radiotherapy on recurrence and survival in early-stage disease: results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol 2007, 14:1943-1952.
17. Garneski K.M., Nghiem P. Merkel cell carcinoma adjuvant therapy: current data support radiation but not chemotherapy. J Am Acad Dermatol 2007, 57:166-169.
18. Mojica P., Smith D., Ellenhorn J.D. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol 2007, 27:1043-1047.
19. Lewis K.G., Weinstock M., Weaver A.L., et al. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol 2006, 142:693-700.
20. Jouary T., Leyral C., Dreno B., et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentre prospective randomized study. Ann Oncol 2012, 23(4):1074-1080.
21. Fang L.C., Lemos B., Douglas J., et al. Radiation monotherapy as regional treatment for lymph node positive Merkel cell carcinoma. Cancer 2010, 116(7):1783-1790.
22. Foote M.H.J., Porceddu S., Dickie G., et al. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Int J Radiat Oncol Biol Phys 2010, 77(3):677-684.
23. Poulsen M.G., Rischin D., Porter I., et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?. Int J Radiat Biol Phys 2006, 64(1):114-119.
24. Bedi C., Seel M., Ramdave S., et al. The use of FDG-PET scanning (PET) in the management of Merkel cell carcinoma (MCC). Int J Radiat Biol Phys 2008, 60(1):S107.
25. Belhocine T., Pierard G., Fruhling J., et al. Clinical added-value of 18 FDG PET in neuroendocrine-merkel cell carcinoma. Oncol Rep 2006, 16(2):347-352.
26. Hui A.C., Stillie A., Seel M., et al. Merkel cell carcinoma: 27 year experience at the Peter Macallum Cancer Centre. Int J Radiat Oncol Biol Phys 2011, 80(5):1430-1435.